clinical trials

Roche Sees Return on $310M Investment with Alnylam’s Phase II Hypertension Win
BioSpace
Thu, 09/7/23 - 10:49 pm
Alnylam
Roche
PAH
zilebesiran
clinical trials
Cytokinetics initiates trial of aficamten to treat nHCM
Clinical Trials Arena
Thu, 09/7/23 - 10:47 am
Cytokinetics
clinical trials
aficamten
non-obstructive hypertrophic cardiomyopathy
Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response
Fierce Biotech
Thu, 09/7/23 - 09:37 am
Pfizer
Lyme disease
vaccines
pediatric
clinical trials
VLA15
Valneva
BioCardia’s Cell Therapy Unlikely to Meet Primary Endpoint in Phase III Heart Failure
BioSpace
Thu, 09/7/23 - 09:33 am
BioCardia
clinical trials
cell therapy
heart failure
CardiAMP
Vaccine experts urge more inclusivity in clinical trials
Stat
Wed, 09/6/23 - 09:49 am
vaccines
RSV
clinical trials
inclusivity
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Tue, 09/5/23 - 11:28 am
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Genmab and Seagen’s TIVDAK trial meets primary endpoint
Clinical Trials Arena
Tue, 09/5/23 - 11:24 am
Genmab
Seagen
Tivdak
clinical trials
cervical cancer
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Fri, 09/1/23 - 12:38 pm
Bayer
Kerendia
clinical trials
heart failure
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
FibroGen fails again in DMD, continuing rotten run of phase 3 flops
Fierce Biotech
Wed, 08/30/23 - 10:09 am
FibroGen
Duchenne Muscular Dystrophy
clinical trials
pamrevlumab
Clene polishes tarnished ALS asset with long-term survival data
Fierce Biotech
Tue, 08/29/23 - 11:25 am
Clene
ALS
clinical trials
CNM-Au8
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Tue, 08/29/23 - 11:15 am
Eli Lilly
muvalaplin
clinical trials
cholesterol
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Mon, 08/28/23 - 08:23 pm
Merck
clinical trials
MK-0616
hypercholesterolemia
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Bayer
cell therapy
Parkinson's Disease
clinical trials
Novartis: Leqvio Provides Low-density Lipoprotein Cholesterol Reduction Beyond 6 Years Of Treatment
RTT News
Mon, 08/28/23 - 12:05 pm
Novartis
Leqvio
LDL cholesterol
clinical trials
Amgen Presents Late-Breaking Phase 2 Olpasiran Data at ESC 2023
BioSpace
Mon, 08/28/23 - 12:02 pm
Amgen
cardiovascular disease
olpasiran
clinical trials
FDA grants clearance to Harbour’s IND for solid tumors therapy trial
Clinical Trials Arena
Mon, 08/28/23 - 11:58 am
Harbour BioMed
clinical trials
HBM9033
solid tumors
Valneva reports data from chikungunya vaccine trial in adolescents
Clinical Trials Arena
Mon, 08/28/23 - 10:44 am
Valneva
clinical trials
VLS1553
chikungunya virus
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Merck
Eisai
Keytruda
Lenvima
clinical trials
head and neck cancer
BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
Yahoo/GlobeNewswire
Sun, 08/27/23 - 04:28 pm
Bridge Bio
clinical trials
acoramidis
ATTR
ATTR-CM

Pages